|
Post by seanismorris on Jun 27, 2014 18:56:04 GMT -5
There seems to be a lot of anger from investors on the yahoo message board.
People seem to be very confused about what just happened today, with regards to the price action.
Quite a few people expected the stock to be up 50%+ on approval.
I'd say, there are a lot of yahoos on Yahoo! (They are probably the ones that sold today at $8.50)
Those people don't understand that the majority of the downside risk has just been eliminated.
We will still have volatility, but the risk/reward has become very favorable to the Longs.
The next milestone Partnership Announcement. (Where we find out what Afrezza is really worth)
It looks like 12$ will be in the rear view mirror very soon, next stop $16 (with partner). Many of the MNKD analysts have disappeared over the last few years. I expect they will be jumping back in very soon (into the Afrezza production run up) helping to maintain the price momentum.
Congratulation's Longs and Diabetics!
|
|
|
Post by garrett on Jun 27, 2014 20:48:15 GMT -5
I agree. This was the major risk facing MannKind's longs not knowing precisely what the FDA would do. Since this approval with a reasonable label is in the bag, a great partnership deal is inevitable. The next risk for longs will be the magnitude of sales is net income in the first quarter or two.
|
|